T-cell immune response to SARS-CoV-2 in healthcare workers 2.5–3 years after COVID-19
- 10 April 2025
- journal article
- Published by Farmarus Print Media in Russian Journal of Allergy
- Vol. 22 (1) , 11-22
Abstract
BACKGROUND: The T cell adaptive immune response is an important factor in the formation of antiviral defense against SARS-CoV-2. AIM: Тo study T cell immunity to the SARS-CoV-2 in healthcare workers of a temporary infectious diseases hospital in Kazan — COVID-19 convalescents 2.5–3 years after the infection using the IGRA-ELISPOT technology. MATERIALS AND METHODS: The immune response to the most SARS-CoV-2 immunogenic peptides S, N, ORF-3a, ORF-7a was studied in 91 healthcare workers of the city of Kazan 2.5–3 years after suffering from COVID-19 of varying severity and varying vaccine status. The results were recorded by the number of formed spots: imprints of one T cell secreting interferon γ in response to antigenic stimulation. The number of obtained spots characterized the content of peripheral blood CD4+ and CD8+ T cells specific for SARS-CoV-2 antigens and made it possible to assess individual immune response. Statistical processing wasperformed using variation statistics methods using the statistical package Excel 2016 and WinPepi Version 11, 65. The relative frequency of a trait (P) and the error in the relative frequency value (m) were calculated. The study results were compared using the χ2-test when the number of observations was more than 5 and Fisher’s exact method when the number of observations was 5 or less. Differences were considered significant at p 0.05. RESULTS: 2.5–3 years after experiencing COVID-19 infection, T-cell immune response to S protein peptides is recorded in 72.53 ± 5.50 %, and to structural peptides N, M, ORF3a and ORF7a in 86.81 ± 3.81 % (χ2-test 5.733; p = 0.017) of medical workers. A higher level of T cell immunity to S protein peptides of the SARS-CoV-2 virus is observed in healthcare workers who have had moderate/severe COVID-19. The preservation of the parameters of hybrid immunity compared to post-infectious immunity is higher, which is significant both for groups with a history of clinical manifestations of COVID-19 and for the group with asymptomatic forms. CONCLUSION: Our empirically established ranking of the number of spots in classes can be used to assess individual cellular immunity and stratify the risks of re-infection in healthcare workers. A negative result of the T cell immune response to the spike S protein antigen may be the basis for deciding whether to re-vaccinate healthcare workers.Keywords
This publication has 15 references indexed in Scilit:
- Identification of conserved immunogenic peptides of SARS-CoV-2 nucleocapsid proteinJournal of Biomolecular Structure and Dynamics, 2023
- Maintaining immunological memory to the SARS-CoV-2 virus during COVID-19 pandemicRussian Journal of Infection and Immunity, 2023
- SARS-CoV-2 accessory proteins ORF7a and ORF3a use distinct mechanisms to down-regulate MHC-I surface expressionProceedings of the National Academy of Sciences, 2022
- ELISPOT assay of the SARS-CoV-2 specific T cells immune responseActa Biomedica Scientifica, 2022
- Antibody and T Cell Immune Responses to SARS-CoV-2 Peptides in COVID-19 Convalescent PatientsFrontiers in Microbiology, 2022
- Assessment of T-cell immunity to SARS-CoV-2 in COVID-19 convalescents and vaccinated subjects, using TigraTest® SARS-CoV-2 ELISPOT kitBiological Products. Prevention, Diagnosis, Treatment, 2021
- Persistence of Antibody and Cellular Immune Responses in Coronavirus Disease 2019 Patients Over Nine Months After InfectionThe Journal of Infectious Diseases, 2021
- Site-specific glycan analysis of the SARS-CoV-2 spikeScience, 2020
- Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent IndividualsImmunity, 2020
- A Conserved Domain in the Coronavirus Membrane Protein Tail Is Important for Virus AssemblyJournal of Virology, 2010